Clearstead Trust’s Innoviva INVA Stock Holding History

Clearstead Trust’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$329	–	1258
2025 Q3	$329	Hold	18	–	–	﹤0.01%	1441
2025 Q2	$362	Buy	+18	New	+$346	﹤0.01%	1393

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's INVA Position: Q4 2025 in Review

Clearstead Trust sold out of Innoviva (INVA) in Q4 2025, closing a stake of 18 shares — an estimated $329 sold.

Clearstead Trust first reported a position in INVA in Q2 2025 and held it in 2 quarters. The position peaked at $362 in Q2 2025. 280 funds tracked by Wall St. Rank hold INVA as of Q4 2025.

Clearstead Trust reported no remaining Innoviva position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 18 Innoviva shares in Q4 2025, an estimated $329.
Clearstead Trust first reported a position in Innoviva in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Innoviva position peaked at $362 in Q2 2025.
280 funds tracked by Wall St. Rank held Innoviva as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.